Shantel Nichole Pettit, CSW | |
3740 W Market Center Dr, #1200, Riverton, UT 84065-8026 | |
(801) 240-9436 | |
Not Available |
Full Name | Shantel Nichole Pettit |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 3740 W Market Center Dr, Riverton, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083047567 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 5987144-3502 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shantel Nichole Pettit, CSW 3740 W Market Center Dr, #1200, Riverton, UT 84065-8026 Ph: (801) 240-9436 | Shantel Nichole Pettit, CSW 3740 W Market Center Dr, #1200, Riverton, UT 84065-8026 Ph: (801) 240-9436 |
News Archive
A team of Canadian physicians and researchers is believed to be the first in the world to have used gene therapy to treat a patient with Fabry disease, a rare inherited enzyme deficiency that can damage major organs and shorten lifespan.
Researchers from Italy say that the majority of hospitalizations for pediatric asthma reflect inadequate disease management rather than disease severity.
Neuroscientists at the University of Bristol have received a major funding boost of -550,000 from the Medical Research Council to continue their research into the pathological processes underpinning Alzheimer's disease, the most common cause of dementia, affecting around 465,000 people in the UK.
Teasing out the exact type or types of dementia someone suffers from is no easy task; neurodegenerative brain diseases share common pathology and often co-occur. Researchers from the Perelman School of Medicine at the University of Pennsylvania are continuing efforts to differentiate diseases, such as Alzheimer's disease (AD) from frontotemporal lobar degeneration (FTLD), as FTLD is often clinically difficult to distinguish from atypical presentations of AD.
Aerovance Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial, of inhaled dry powder Aerovant in patients with uncontrolled asthma.
› Verified 8 days ago
Cathi Sessions, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1273 W 12600 S Ste 403, Riverton, UT 84065 Phone: 801-930-0411 | |
Breeana Welch, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11978 S Redwood Rd Ste B, Riverton, UT 84065 Phone: 801-679-3921 | |
Ashley Eryn Steineckert, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1273 West 12600 South, Ste 403, Riverton, UT 84065 Phone: 801-930-0411 Fax: 801-931-2211 | |
Ashley Higa Miller, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1273 W 12600 S Ste 403, Riverton, UT 84065 Phone: 443-975-6577 | |
Ms. Tracie Lynn Baldwin, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1262 W 12700 S, Suite D, Riverton, UT 84065 Phone: 385-468-4610 Fax: 385-468-4611 | |
Lindsey Ann Macfarlane, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 12427 S Pasture Rd Ste 104, Riverton, UT 84096 Phone: 801-727-8744 |